Novavax Q3 beat overshadowed by stock drop as milestone-driven outlook raise fails to convince

What happened

Novavax reported third-quarter earnings and revenue that beat analyst expectations, with costs declining year over year, but shares fell 8% on the news. The company also announced a Sanofi-related milestone that drove a sharp increase in its 2026 outlook. Despite the positive headline numbers, investors appeared skeptical, likely because the beat was driven by a one-time milestone rather than recurring royalty growth. The master report had flagged that the transition from upfront payments to sustainable royalties was not yet evident, and the Q3 results may not alter that concern. The stock's decline suggests the market is focusing on the quality of earnings and the durability of revenue streams.

Implication

The Q3 beat and improved 2026 outlook are positive but may be skewed by the Sanofi milestone, which is a lumpy one-time item rather than recurring revenue. The market's negative reaction indicates that investors are discounting the improvement and focusing on the underlying weakness in core vaccine sales and royalties. Novavax still faces execution risk in converting its partnership deals into consistent royalty income, and the stock may remain range-bound until there is clearer evidence of scaling royalties. The master report's WAIT rating remains appropriate, with a trim above $12 and entry near $7, and the current price likely remains in that range. Investors should monitor quarterly royalty trends and additional milestones before reassessing, as the stock's reaction shows that headline beats are not sufficient to drive sustained upside.

Thesis delta

The thesis is largely unchanged, as the Q3 results do not yet show a shift to durable royalty economics. The Sanofi milestone improves near-term revenue and outlook but is a one-time event that may mask slower progress on recurring royalties. We maintain a WAIT stance, and the market's negative reaction reinforces the need for patience until royalties scale.